Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma
- PMID: 6692408
Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma
Abstract
Utilizing double-determinant immunoassays (DDIAs), the high-molecular-weight melanoma-associated antigen (HMW-MAA) was detected only in fetal skin and in one nipple of 54 normal tissues from adults tested, while the cytoplasmic MAA recognized by the monoclonal antibody 465. 12S was found in most of the normal tissues tested. Among malignant lesions, the HMW-MAA was found in melanomas, astrocytomas, and skin carcinomas; the cytoplasmic MAA was found in all of the malignant lesions tested, even those which originated from normal tissues without detectable cytoplasmic MAA. The levels of the HMW-MAA and of the cytoplasmic MAA showed marked variations in malignant lesions removed from various patients, as well as in autologous metastatic lesions removed from four patients with melanoma. No relationship was found between the degree of expression of the two MAA analyzed and the clinical stage of the disease. Both types of MAA were found in sera from patients with melanoma or other types of cancers, as well as in sera from healthy donors. The level of the HMW-MAA tended to be higher in patients with Stage IV melanoma.
Similar articles
-
Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.Cancer Res. 1993 Jun 15;53(12):2830-3. Cancer Res. 1993. PMID: 8504426
-
Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.Cancer Res. 1987 May 1;47(9):2474-80. Cancer Res. 1987. PMID: 3552215
-
Antigenic heterogeneity of skin tumors of nonmelanocyte origin: analysis with monoclonal antibodies to tumor-associated antigens and to histocompatibility antigens.J Natl Cancer Inst. 1983 Sep;71(3):439-47. J Natl Cancer Inst. 1983. PMID: 6577218
-
Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanisms.Ann N Y Acad Sci. 2004 Dec;1028:340-50. doi: 10.1196/annals.1322.040. Ann N Y Acad Sci. 2004. PMID: 15650259 Review.
-
Human melanoma-associated antigens.Immunol Ser. 1989;43:643-79. Immunol Ser. 1989. PMID: 2490510 Review.
Cited by
-
In vitro differentiation and antigenic changes in human melanoma cell lines.Cancer Immunol Immunother. 1989;30(5):262-8. doi: 10.1007/BF01744892. Cancer Immunol Immunother. 1989. PMID: 2624919 Free PMC article.
-
Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.J Clin Invest. 1990 Dec;86(6):2136-44. doi: 10.1172/JCI114952. J Clin Invest. 1990. PMID: 2254463 Free PMC article. Clinical Trial.
-
Circulating melanoma-associated antigen detected by monoclonal antibody NKI/C-3.Cancer Immunol Immunother. 1986;23(2):93-100. doi: 10.1007/BF00199813. Cancer Immunol Immunother. 1986. PMID: 2430706 Free PMC article.
-
Immunodiagnosis of human malignancy.Ann Surg. 1985 Apr;201(4):415-22. doi: 10.1097/00000658-198504000-00003. Ann Surg. 1985. PMID: 3883922 Free PMC article.
-
Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):466-70. doi: 10.1073/pnas.89.2.466. Proc Natl Acad Sci U S A. 1992. PMID: 1731316 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical